David Glenn Koch MD MSCR
Hepatology & Liver Transplantation
Hepatology Section Chief GI Fellowship Associate Program Director of Research Professor, Medicine, Medical University of South Carolina College of Medicine
Join to View Full Profile
25 Courtenay DrCharleston, SC 29425
Phone+1 843-792-6982
Dr. Koch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Medical University of South CarolinaFellowship, Gastroenterology, 2004 - 2007
University of Alabama Medical CenterResidency, Internal Medicine, 2001 - 2004
Louisiana State University School of Medicine in New OrleansClass of 2001
Certifications & Licensure
ME State Medical License 2020 - 2025
SC State Medical License 2004 - 2025
AL State Medical License 2002 - 2004
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury Start of enrollment: 2012 Jun 01
Publications & Presentations
PubMed
- 1 citationsObjective Measures of Cardiometabolic Risk and Advanced Fibrosis Risk Progression in Primary Care Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.Andrew D Schreiner, Jingwen Zhang, William P Moran, David G Koch, Justin Marsden
Endocrine Practice. 2024-11-01 - FIB-4 as a Time-varying Covariate and Its Association With Severe Liver Disease in Primary Care: A Time-dependent Cox Regression Analysis.Andrew D Schreiner, Jingwen Zhang, William P Moran, David G Koch, Justin Marsden
Journal of Clinical Gastroenterology. 2024-10-01 - H2FPEF Scores Are Increased in Patients with NASH Cirrhosis and Are Associated with Post-liver Transplant Heart Failure.David G Koch, Don C Rockey, Sheldon S Litwin, Ryan J Tedford
Digestive Diseases and Sciences. 2024-08-01
Journal Articles
- Use of Intra‐Aortic Counterpulsation in Cardiogenic Shock Post‐Liver TransplantationGabriel R Chedister, William D Stoll, Kenneth D Chavin, John W McGillicuddy, Satish N Nadig, David G Koch, Clinical Transplantation
Press Mentions
First Edition: April 23, 2020April 23rd, 2020
Grant Support
- Novel Mechanisms of Hepatopulmonary SyndromeNIH/NHLBI2018–2024
- TARGET-HCC: A Longitudinal Observational Study of the Natural History and Management of Patients with Hepatocellular CarcinomaTARGET-RWE2016–2024
- TARGET-NASH: A 5-year, Longitudinal, Observational Study of Patients with Nonalcoholic Fatty Liver Disease or Nonalcoholic SteatohepatitisTARGET-RWE2016–2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
